Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-05 Purchase | 2022-05-09 4:42 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 100,000 | $13.5 | $1,350,000 | 1,304,016 (Indirect Direct) | View |
| 2022-05-05 Sale | 2022-05-05 6:55 pm | Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner | 5,374 | $12.25 | $65,832 | 2,469,001 (Indirect) | View |
| 2022-05-02 Sale | 2022-05-04 8:01 pm | Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner | 512,956 | $13.39 | $6,866,311 | 2,474,375 (Indirect) | View |
| 2021-12-01 Sale | 2021-12-03 6:56 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 5,833 | $24.68 | $143,934 | 1,204,016 (Direct) | View |
| 2021-12-01 Sale | 2021-12-03 6:55 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. CEO | 5,833 | $24.72 | $144,167 | 1,205,856 (Indirect Direct) | View |
| 2021-11-08 Sale | 2021-11-10 6:29 pm | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 1,889 | $28.11 | $53,100 | 50,203 (Direct) | View |
| 2021-11-04 Sale | 2021-11-08 5:49 pm | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 111 | $28.04 | $3,112 | 52,092 (Direct) | View |
| 2021-11-02 Sale | 2021-11-04 7:03 pm | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 6,000 | $26.78 | $160,690 | 52,203 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 7:00 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 5,833 | $27.82 | $162,289 | 1,209,849 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 6:55 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. CEO | 5,833 | $27.82 | $162,284 | 1,211,689 (Indirect Direct) | View |
| 2021-10-12 Sale | 2021-10-14 4:48 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 5,633 | $26.27 | $148,000 | 1,215,682 (Direct) | View |
| 2021-10-12 Sale | 2021-10-14 4:44 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. CEO | 5,531 | $26.3 | $145,448 | 1,217,522 (Indirect Direct) | View |
| 2021-10-08 Sale | 2021-10-12 6:47 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 200 | $25.03 | $5,006 | 1,221,315 (Direct) | View |
| 2021-10-08 Sale | 2021-10-12 6:43 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. CEO | 302 | $25.02 | $7,555 | 1,223,053 (Indirect Direct) | View |
| 2021-09-10 Sale | 2021-09-14 4:51 pm | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 2,593 | $22.15 | $57,435 | 73,964 (Direct) | View |
| 2021-09-01 Sale | 2021-09-03 6:53 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 5,833 | $25.24 | $147,237 | 1,221,515 (Direct) | View |
| 2021-09-01 Sale | 2021-09-03 5:51 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. CEO | 5,833 | $25.25 | $147,301 | 1,223,355 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-15 Other | 2022-08-17 4:22 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 219,324 | $0 | 362,053 (Indirect) | View |
| 2022-06-16 Option Award | 2022-07-01 12:31 pm | N/A 2032-06-15 | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-07-01 12:30 pm | N/A 2032-06-15 | Tarsus Pharmaceuticals Inc. | TARS | CHAUDHURI BHASKAR Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-07-01 12:29 pm | N/A 2032-06-15 | Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-07-01 12:28 pm | N/A 2032-06-15 | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-07-01 12:23 pm | N/A 2032-06-15 | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-07-01 12:21 pm | N/A 2032-06-15 | Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-07-01 12:18 pm | N/A 2032-06-15 | Tarsus Pharmaceuticals Inc. | TARS | Crane Rosemary A Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2022-06-15 Exercise | 2022-06-17 4:51 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 4,257 | $0 | 1,308,273 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 4:19 pm | N/A 2032-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. CEO | 199,264 | $0 | 199,264 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 4:17 pm | N/A 2032-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 89,886 | $0 | 89,886 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 4:15 pm | N/A 2032-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 118,643 | $0 | 118,643 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 4:13 pm | N/A 2032-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. VP | 46,785 | $0 | 46,785 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 4:10 pm | N/A 2032-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 84,472 | $0 | 84,472 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 4:07 pm | N/A 2032-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 112,867 | $0 | 112,867 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 4:04 pm | N/A 2032-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. CFO | 78,696 | $0 | 78,696 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 5:36 pm | N/A 2032-01-31 | Tarsus Pharmaceuticals Inc. | TARS | Trevejo Jose M. CHIEF MEDICAL OFFICER | 146,621 | $0 | 146,621 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-04 9:10 pm | N/A 2031-12-31 | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-12-31 Ownership | 2022-01-04 9:09 pm | N/A 2030-05-13 | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Director | 0 | $0 | 45,134 (Direct) | View |
| 2021-11-11 Other | 2021-11-16 7:58 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 254,348 | $0 | 393,328 (Indirect) | View |
| 2021-09-10 Exercise | 2021-09-14 4:51 pm | N/A 2028-09-13 | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 2,593 | $0.45 | 73,964 (Direct) | View |
| 2021-09-10 Exercise | 2021-09-14 4:51 pm | N/A 2030-09-24 | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 4,350 | $10.99 | 73,964 (Direct) | View |
| 2021-08-11 Option Award | 2021-08-12 7:28 pm | N/A 2031-08-11 | Tarsus Pharmaceuticals Inc. | TARS | Crane Rosemary A Director | 20,000 | $0 | 20,000 (Direct) | View |